London, UK (PRWEB) November 20, 2013
After witnessing a decline during 2011-2012, the peripheral vascular (PV) devices and accessories market in the US is currently experiencing robust growth and is likely to recover by the end of 2013. The key factors driving rapid growth of the domestic market include ongoing technological innovations and advancements, continuously increasing healthcare expenditures, demographic changes in the country, growing public awareness, and also an expanding pool of potential patients. At present, there are around 10 million people in the US suffering from peripheral arterial disease (PAD). PDA has traditionally been treated by the usage of stenting and ballon angioplasty. Together, these two markets are expected to be worth USD 1.3 billion by end-2013, thus accounting for approximately 30% of the country’s overall peripheral vascular device market.
Abbott Laboratories, Atrium Medical, Boston Scientific, Cordis, Endologix, Medtronic, Pfizer and Cardiovascular Systems Inc are among the top companies playing in the US market for peripheral vascular devices and accessories.
New market research report “U.S. Market for Peripheral Vascular Devices and Accessories” worked out by iData Research has been recently published by Market Publishers Ltd.
Title: U.S. Market for Peripheral Vascular Devices and Accessories
Published: November, 2013
Price: US$ 6,995.00
The report provides an insightful guide to the peripheral vascular devices and accessories market in the US. It describes the actual situation in the market and sheds light on the historical background, presents an in-depth examination of sub-markets, discloses vital information on the product average selling volumes and prices. The research study outlines the main market opportunities and challenges, discusses the strategies for a successful navigation of the market landscape, scrutinizes the key market limiters and drivers. The evaluation of the competitive pressure, profiles of the leading companies, and coverage of the recent mergers and acquisitions are also available in the study. In addition, the report presents a detailed market future outlook and identifies the forces that will influence the future of each sub-market examined.
Sub-segments covered in the report include: oocyte retrieval needles, micropipettes, embryo transfer catheters, reproduction media, manipulation media, uterine balloon therapy, hydrothermal ablation, radiofrequency ablation, cryoablation, microwave ablation, monopolar electrodes, bipolar electrodes, resectoscope, uterine fibroid embolization devices, microsphere, PVA particle, rigid & flexible hysteroscopes, mechanical sterilization devices, bipolar sterilization devices, synthetic & non-synthetic slkings, home-based & office-based pelvic floor electrical stimulation devices, capital equipment, tubing, transvaginal mesh and sacrocolpopexy mesh.
More new market research reports by the publisher can be found at iData Research page.
Read the full story at http://www.prweb.com/releases/2013/11/prweb11353468.htm.
Copyright©2012 Vocus, Inc.
All rights reserved